Comparison of the effects of intravitreal bevacizumab and dexamethasone in experimental posterior penetrating eye injury.

Oner, Ayse; Kahraman, Nisa; Ozdamar, Saim; Balcioglu, Esra

Oner, Ayse; Kahraman, Nisa; Ozdamar, Saim; Balcioglu, Esra.

Afiliação

Oner A; Department of Ophthalmology, Faculty of Medicine, Erciyes University, Kayseri 38039, Turkey.
Kahraman N; Department of Ophthalmology, Faculty of Medicine, Erciyes University, Kayseri 38039, Turkey.
Ozdamar S; Department of Histology and Embryology, Faculty of Medicine, Erciyes University, Kayseri 38039, Turkey.
Balcioglu E; Department of Histology and Embryology, Faculty of Medicine, Erciyes University, Kayseri 38039, Turkey.

Int J Ophthalmol ; 11(4): 575-579, 2018.

Article em En | MEDLINE | ID: mdl-29675373

Palavras-chave

bevacizumab; dexamethasone; experimental; posterior penetrating ocular injury; proliferative vitreoretinopathy

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Int J Ophthalmol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Turquia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google